Long-acting injectables: Overcoming challenges and implementing best practice
Join Professors David Castle, John Kane and Philip Gorwood as they provide expert opinion on crucial aspects of treating patients with schizophrenia and the use of long-acting injectables (LAIs) in practice, including normalising non-adherence, increasing acceptance of LAIs, treating younger male patients, and when and how to initiate therapy. Watch the videos or listen to the podcast.
